A non-conventional food-grade yeast engineered to produce indigoidine, a stable blue pigment with antimicrobial and antioxidant properties. The bioprocess uses low-cost feedstocks such as lignocellulosic hydrolysates and waste cooking oil and achieves gram-per-liter production titres in bioreactor fermentation. Pigment stability is demonstrated under thermal, acidic, light, and cold-storage conditions, supporting food and beverage colorant use. GRAS status from the FDA is cited to support regulatory pathways.
This solution leverages an engineered non-conventional food yeast to produce indigoidine, an intense blue pigment with demonstrated antimicrobial and antioxidant activities. The bioprocess offers a sustainable alternative to synthetic blue colorants, which face increasing regulatory and consumer scrutiny in food and beverage applications. Production has been validated at gram-per-liter scale using inexpensive, locally sourced feedstocks including lignocellulosic hydrolysates and waste cooking oil, supporting cost-effective manufacturing. The underlying yeast and its products have received GRAS (Generally Recognized as Safe) status from the FDA, which is expected to streamline regulatory approval for the pigment. Additional yeast strains producing yellow, orange, and red pigments are also available, enabling a full spectrum of natural color solutions for food and beverage applications.
Key features:
The technology has been validated at laboratory and bioreactor scale, with demonstrated production titres in the gram-per-liter range. Pigment stability has been confirmed under conditions relevant to food and beverage processing, including thermal exposure, acidic pH, light exposure, and cold storage. Ongoing work aims to increase indigoidine titres through genetic and process engineering of the production strain, and to assess long-term stability to meet commercial shelf-life requirements. A planned collaboration is intended to evaluate commercial potential, regulatory pathways, and safety assessments. Organising tasting panels to evaluate sensory impact on beverages is also planned. The technology is positioned at TRL 4–5, with demonstrated feasibility at relevant scale and active development toward commercial readiness.
Imperial College London is a STEM‑focused public research university with a large postgraduate community and an entrepreneurial culture. Industry engages through the White City innovation district, where the university offers incubator and scale‑up labs, wet‑lab and prototyping facilities, co‑location with corporate R&D and startups, and a dedicated technology transfer office. Integration with a major NHS hospital system provides access to clinical cohorts, trials infrastructure, and translational expertise, while corporate relations streamline sponsored research and consortia. Research is supported by competitive funding from UK Research and Innovation councils, the National Institute for Health and Care Research, European programs, and major foundations.